Close Menu

NEW YORK (GenomeWeb) – Somalogic and DeCode Genetics announced today that they are collaborating on a proteomic analysis of up to 40,000 of DeCode's patient samples.

The analysis will use Somalogic's SomaScan platform, which measures the levels of 5,000 proteins using the company's Somamer affinity reagents. According to the firms, Reykjavik-based DeCode will use the data gathered through this analysis for drug discovery and development work, while Boulder, Colorado-based Somalogic will use the findings to develop clinical applications of the SomaScan platform.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.

A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.

Broad Institute researchers describe an approach they've dubbed "DNA microscopy."

In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.